Skip to main content
Viewing from:
Department GEZ-LTA Erasmushogeschool
Intended for healthcare professionals
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
For authors
Podcasts
About
Hosted content
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
For authors
Podcasts
About
Hosted content
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
More
You are viewing from:
Department GEZ-LTA Erasmushogeschool
You are here
Home
Archive
Volume 96, Issue 3
Guidance for clinical management of pathogenic variant carriers at elevated genetic risk for ALS/FTD
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Neurodegeneration
Review
Guidance for clinical management of pathogenic variant carriers at elevated genetic risk for ALS/FTD
Online download statistics by month:
Online download statistics by month: November 2024 to April 2025
Abstract
Full
Pdf
Nov 2024
1250
1254
417
Dec 2024
698
660
336
Jan 2025
1634
1615
277
Feb 2025
1879
1867
293
Mar 2025
669
649
241
Apr 2025
541
528
223
Total
6671
6573
1787
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF